First City Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

First City Capital Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-150	Closed	-$11.9K	–	508
2016 Q1	$11.9K	Hold	150	–	–	0.01%	447
2015 Q4	$18.9K	Hold	150	–	–	0.01%	394
2015 Q3	$15.6K	Hold	150	–	–	0.01%	405
2015 Q2	$18.5K	Hold	150	–	–	0.01%	376
2015 Q1	$17.7K	Hold	150	–	–	0.01%	375
2014 Q4	$17.8K	Hold	150	–	–	0.01%	390
2014 Q3	$16.8K	Hold	150	–	–	0.01%	380
2014 Q2	$14.2K	Hold	150	–	–	0.01%	423
2014 Q1	$10.6K	Buy	+150	New	+$11.9K	0.01%	437

Other funds holding VRTX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

First City Capital Management's VRTX Position: Q2 2016 in Review

First City Capital Management sold out of Vertex Pharmaceuticals (VRTX) in Q2 2016, closing a stake of 150 shares — an estimated $11.9K sold.

First City Capital Management first reported a position in VRTX in Q1 2014 and held it in 9 quarters. The position peaked at $18.9K in Q4 2015. 482 funds tracked by Wall St. Rank hold VRTX as of Q2 2016.

First City Capital Management reported no remaining Vertex Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
First City Capital Management sold 150 Vertex Pharmaceuticals shares in Q2 2016, an estimated $11.9K.
First City Capital Management first reported a position in Vertex Pharmaceuticals in Q1 2014 and held it in 9 quarters.
First City Capital Management's Vertex Pharmaceuticals position peaked at $18.9K in Q4 2015.
482 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2016.

Based on First City Capital Management's 13F filing for Q2 2016, filed 16 Aug 2016.